# Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma

> **NCT04270929** · PHASE1 · WITHDRAWN · sponsor: **Roger Williams Medical Center**

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** FOLFIRI
- **DRUG:** FOLFIRINOX
- **DEVICE:** TriSalus Infusion System

## Key facts

- **NCT ID:** NCT04270929
- **Lead sponsor:** Roger Williams Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12-23
- **Primary completion:** 2021-05-04
- **Final completion:** 2021-05-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Insufficient accrual rate
- **Last updated:** 2021-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270929, "Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04270929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*